Given that IL-1β can trigger a broad range of responses that drive systemic inflammation and exacerbate damage during chronic disease, we hypothesized that inhibition of this cytokine would limit disease severity in a lupus-prone mouse model. The gene discussed is IL1B; the disease is systemic lupus erythematosus.